Nura

About:

Nura is a development stage biotechnology company focused on the discovery of therapeutics for behavioral disorders.

Top Investors: Novartis Venture Fund, Vulcan Capital, ARCH Venture Partners, Puget Sound Venture Club, Aravis Ventures

Description:

Nura, Inc. purpose of discovering and developing pharmaceuticals for the treatment of neurodegenerative diseases, such as Parkinson’s and Alzheimers’s diseases, and behavioral disorders, such as depression, anxiety, schizophrenia, obesity and addiction.

Total Funding Amount:

$9.5M

Headquarters Location:

Seattle, Washington, United States

Founded Date:

2003-08-01

Founders:

George A. Gaitanaris

Number of Employees:

11-50

Last Funding Date:

2016-12-01

IPO Status:

Private

Industries: